Atrial fibrillation pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
Line 17: Line 17:
Fibrosis is not limited to the muscle mass of the atria, and may occur in the [[sinus node]] (SA node) and [[atrioventricular node]] (AV node), correlating with [[sick sinus syndrome]].  Prolonged episodes of atrial fibrillation have been shown to correlate with prolongation of the sinus node recovery time,<ref name="pmid16908781">{{cite journal |author=Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL |title=ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society |journal=[[Circulation]] |volume=114 |issue=7 |pages=e257–354 |year=2006 |month=August |pmid=16908781 |doi=10.1161/CIRCULATIONAHA.106.177292 |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=16908781 |issn=}}</ref>  
Fibrosis is not limited to the muscle mass of the atria, and may occur in the [[sinus node]] (SA node) and [[atrioventricular node]] (AV node), correlating with [[sick sinus syndrome]].  Prolonged episodes of atrial fibrillation have been shown to correlate with prolongation of the sinus node recovery time,<ref name="pmid16908781">{{cite journal |author=Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL |title=ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society |journal=[[Circulation]] |volume=114 |issue=7 |pages=e257–354 |year=2006 |month=August |pmid=16908781 |doi=10.1161/CIRCULATIONAHA.106.177292 |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=16908781 |issn=}}</ref>  
<ref name="pmid8941126">{{cite journal |author=Elvan A, Wylie K, Zipes DP |title=Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling |journal=[[Circulation]] |volume=94 |issue=11 |pages=2953–60 |year=1996 |month=December |pmid=8941126 |doi= |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=8941126 |issn=}}</ref>
<ref name="pmid8941126">{{cite journal |author=Elvan A, Wylie K, Zipes DP |title=Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling |journal=[[Circulation]] |volume=94 |issue=11 |pages=2953–60 |year=1996 |month=December |pmid=8941126 |doi= |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=8941126 |issn=}}</ref>
<ref name="pmid11469431">{{cite journal |author=Manios EG, Kanoupakis EM, Mavrakis HE, Kallergis EM, Dermitzaki DN, Vardas PE |title=Sinus pacemaker function after cardioversion of chronic atrial fibrillation: is sinus node remodeling related with recurrence? |journal=[[Journal of Cardiovascular Electrophysiology]] |volume=12 |issue=7 |pages=800–6 |year=2001 |month=July |pmid=11469431 |doi= |url= |issn=}}</ref>
<ref name="pmid11469431">{{cite journal |author=Manios EG, Kanoupakis EM, Mavrakis HE, Kallergis EM, Dermitzaki DN, Vardas PE |title=Sinus pacemaker function after cardioversion of chronic atrial fibrillation: is sinus node remodeling related with recurrence? |journal=[[Journal of Cardiovascular Electrophysiology]] |volume=12 |issue=7 |pages=800–6 |year=2001 |month=July |pmid=11469431 |doi= |url= |issn=}}</ref> suggesting that dysfunction of the [[SA node]] is progressive with prolonged episodes of atrial fibrillation.
suggesting that dysfunction of the [[SA node]] is progressive with prolonged episodes of atrial fibrillation.


==References==
==References==

Revision as of 13:22, 19 April 2011

WikiDoc Resources for Atrial fibrillation pathophysiology

Articles

Most recent articles on Atrial fibrillation pathophysiology

Most cited articles on Atrial fibrillation pathophysiology

Review articles on Atrial fibrillation pathophysiology

Articles on Atrial fibrillation pathophysiology in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Atrial fibrillation pathophysiology

Images of Atrial fibrillation pathophysiology

Photos of Atrial fibrillation pathophysiology

Podcasts & MP3s on Atrial fibrillation pathophysiology

Videos on Atrial fibrillation pathophysiology

Evidence Based Medicine

Cochrane Collaboration on Atrial fibrillation pathophysiology

Bandolier on Atrial fibrillation pathophysiology

TRIP on Atrial fibrillation pathophysiology

Clinical Trials

Ongoing Trials on Atrial fibrillation pathophysiology at Clinical Trials.gov

Trial results on Atrial fibrillation pathophysiology

Clinical Trials on Atrial fibrillation pathophysiology at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Atrial fibrillation pathophysiology

NICE Guidance on Atrial fibrillation pathophysiology

NHS PRODIGY Guidance

FDA on Atrial fibrillation pathophysiology

CDC on Atrial fibrillation pathophysiology

Books

Books on Atrial fibrillation pathophysiology

News

Atrial fibrillation pathophysiology in the news

Be alerted to news on Atrial fibrillation pathophysiology

News trends on Atrial fibrillation pathophysiology

Commentary

Blogs on Atrial fibrillation pathophysiology

Definitions

Definitions of Atrial fibrillation pathophysiology

Patient Resources / Community

Patient resources on Atrial fibrillation pathophysiology

Discussion groups on Atrial fibrillation pathophysiology

Patient Handouts on Atrial fibrillation pathophysiology

Directions to Hospitals Treating Atrial fibrillation pathophysiology

Risk calculators and risk factors for Atrial fibrillation pathophysiology

Healthcare Provider Resources

Symptoms of Atrial fibrillation pathophysiology

Causes & Risk Factors for Atrial fibrillation pathophysiology

Diagnostic studies for Atrial fibrillation pathophysiology

Treatment of Atrial fibrillation pathophysiology

Continuing Medical Education (CME)

CME Programs on Atrial fibrillation pathophysiology

International

Atrial fibrillation pathophysiology en Espanol

Atrial fibrillation pathophysiology en Francais

Business

Atrial fibrillation pathophysiology in the Marketplace

Patents on Atrial fibrillation pathophysiology

Experimental / Informatics

List of terms related to Atrial fibrillation pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Pathophysiology of Atrial Fibrillation

The primary pathologic change seen in atrial fibrillation is the progressive fibrosis of the atria. This fibrosis is primarily due to atrial dilatation, however genetic causes and inflammation may have a cause in some individuals.

Dilatation of the atria can be due to almost any structural abnormality of the heart that can cause a rise in the intra-cardiac pressures. This includes valvular heart disease (such as mitral stenosis, mitral regurgitation, and tricuspid regurgitation), hypertension, and congestive heart failure. Any inflammatory state that affects the heart can cause fibrosis of the atria. This is typically due to sarcoidosis but may also be due to autoimmune disorders that create autoantibodies against myosin heavy chains. Mutation of the lamin AC gene is also associated with fibrosis of the atria that can lead to atrial fibrillation.

Once dilatation of the atria has occurred, this begins a chain of events that leads to the activation of the renin aldosterone angiotensin system (RAAS) and subsequent increase in matrix metaloproteinases and disintegrin, which leads to atrial remodeling and fibrosis, with loss of atrial muscle mass.

This process is not immediate, and experimental studies have revealed patchy atrial fibrosis may precede the occurrence of atrial fibrillation and may progress with prolonged durations of atrial fibrillation.

Fibrosis is not limited to the muscle mass of the atria, and may occur in the sinus node (SA node) and atrioventricular node (AV node), correlating with sick sinus syndrome. Prolonged episodes of atrial fibrillation have been shown to correlate with prolongation of the sinus node recovery time,[1] [2] [3] suggesting that dysfunction of the SA node is progressive with prolonged episodes of atrial fibrillation.

References

  1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL (2006). "ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation. 114 (7): e257–354. doi:10.1161/CIRCULATIONAHA.106.177292. PMID 16908781. Unknown parameter |month= ignored (help)
  2. Elvan A, Wylie K, Zipes DP (1996). "Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling". Circulation. 94 (11): 2953–60. PMID 8941126. Unknown parameter |month= ignored (help)
  3. Manios EG, Kanoupakis EM, Mavrakis HE, Kallergis EM, Dermitzaki DN, Vardas PE (2001). "Sinus pacemaker function after cardioversion of chronic atrial fibrillation: is sinus node remodeling related with recurrence?". Journal of Cardiovascular Electrophysiology. 12 (7): 800–6. PMID 11469431. Unknown parameter |month= ignored (help)

Template:WH

Template:WS